Biosimulation is quantitative drug development that powers decision making. Modeling and simulation are proven effective and efficient alternatives to real-world clinical trials. The result is enabling our clients to make better medicines available to patients sooner.
Biosimulation Software
Empirical and mechanistic modeling solutions to support all phases of drug development
Contact us
Our biosimulation software suite
The industry's most trusted PK/PD platform for non-compartmental analysis (NCA), population PK (popPK), IVIVC, and more.
Our PBPK modeling software is the most widely adopted platform for PBPK modeling in drug development. Find out more about
Certara's QSP modeling software enables modelers and scientists to predict drug efficacy and safety utilizing mathematical modeling and virtual trials.
Related resources
View allContact us
We know – we have a formidable and comprehensive range of software products. Ask us to help navigate you to the right product. Whether you know your product of interest or not, send an inquiry and we’ll do our utmost to connect you to the platform that serves you best.
>90% of all novel drugs approved by the US FDA since 2014 were supported by Certara solutions.
Seamlessly integrate the right expert at any development stage.
Reduce timelines, costs, and risks with our proven, trusted solutions.
Send an Inquiry
